MarketWatchMarketWatch (Photo credit: Wikipedia)

Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary — Regen BioPharma Inc., Secures $20,000,000 in Institutional Funding – MarketWatch.

SAN DIEGO, CA, Apr 30, 2012 (MARKETWIRE via COMTEX) — Bio-Matrix Scientific Group, Inc. (otcqb:BMSN) (pinksheets:BMSN) announced today it has formed a new subsidiary, Regen BioPharma, Inc. Regen BioPharma has developed a vertically-integrated structure for acquiring patents, performing accelerating preclinical and clinical development, and licensing or selling technology developed to large pharma companies in the area of stem cells. Read More

Enhanced by Zemanta